References

Bradberry JC, Fagan SC. “Stroke.” Pharmacotherapy. Fifth Edition. 2002. McGraw-Hill. New York. pp. 375-394.

Eggimann P, Pittet D. “Infection Control in the ICU.” Chest. December 2001. Vol. 120. No. 6.

“Enoxaparin.” AHFS (online) 2002.

Erdman, SM. et. al. “Thromboembolic Disorders.” Pharmacotherapy. Fifth Edition. 2002. McGraw-Hill. New York. pp.337 -373.

“Dalteparin.” AHFS (online) 2002.

Gilbert, DN, et al. “Complicated UTI/Catheters,”The Sanford Guide to Antimicrobial Therapy. 32nd Edition. 2002. pp. 24.

Gilbert, DN, et al. “Hospital-acquired +/- mechanical ventilation,” The Sanford Guide to Antimicrobial Therapy. 32nd Edition. 2002. pp. 27.

“Heparin.” AHFS (online) 2002.

Lacy, C. et. al. “Enoxaparin.” Drug Information Handbook. Eighth Edition. 2000-2001. Lexi-Comp Inc. Cleveland. pp. 418-419.

Lacy, C. et. al. “Dalteparin.” Drug Information Handbook. Eighth Edition. 2000-2001. Lexi-Comp Inc. Cleveland. pp. 320-321.

Lacy, C. et. al. “Warfarin.” Drug Information Handbook. Eighth Edition. 2000-2001. Lexi-Comp Inc. Cleveland. pp. 1256-1259.

“Mannitol.” AHFS (online) 2002.

Qureshi A, Suarez J. “Use of hypertonic saline solutions in treatment of cerebral edema and intracranial pressure.” Critical Care Medicine. September 2000. Vol. 8. No. 9. pp. 3301-3313.

Steiner, T. et. al. “Treatment options for large hemispheric stroke.” Neurology. September 11, 2001. Vol. 57. No. 5.

Toung, T. et. al. “Global brain water increases after experimental focal cerebral ischemia: Effect of hypertonic saline.” Critical Care Medicine. March 2002. Vol. 30. No. 3.

“Warfarin.” AHFS (online) 2002.